Article Information
History
- November 4, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Joseph D. Szustakowski1,
- Suganthi Balasubramanian2,
- Ariella Sasson1,
- Shareef Khalid2,
- Paola G. Bronson3,
- Erika Kvikstad1,
- Emily Wong4,
- Daren Liu2,
- J. Wade Davis5,
- Carolina Haefliger7,
- A. Katrina Loomis8,
- Rajesh Mikkilineni4,
- Hyun Ji Noh5,
- Samir Wadhawan1,
- Xiaodong Bai2,
- Alicia Hawes2,
- Olga Krasheninina2,
- Ricardo Ulloa2,
- Alex Lopez2,
- Erin N. Smith4,
- Jeff Waring5,
- Christopher D. Whelan3,
- Ellen A. Tsai3,
- John Overton2,
- William Salerno2,
- Howard Jacob5,
- Sandor Szalma4,
- Heiko Runz3,
- Greg Hinkle6,
- Paul Nioi6,
- Slavé Petrovski7,
- Melissa R. Miller8,
- Aris Baras2,
- Lyndon Mitnaul2,
- Jeffrey G. Reid2,* and
- on behalf of the UKB-ESC Research Team
- 1Bristol Myers Squibb, Route 206 and Province Line Road, Princeton, NJ 08543
- 2Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591
- 3Biogen Inc., 225 Binney Street, Cambridge, MA 02139
- 4Takeda Pharmaceutical Company Ltd, 1-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo, Japan
- 5Abbvie Inc., 1 N. Waukegan Rd, North Chicago, IL 60064
- 6Alnylam Pharmaceuticals, 675 West Kendall St, Cambridge, MA 02142
- 7AstraZeneca Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, Cambridge, UK
- 8Pfizer, Inc., 1 Portland St., Cambridge, MA 02139
- ↵*Corresponding author; email: jeffrey.reid{at}regeneron.com